Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas

Laboratory Investigation

Volumn 78, Issue 6, 1998, Pages 743-753

  Nenninger, Regina ^a   Schultz, Anja ^a   Hoffacker, Viola ^a   Helmreich, Markus ^a   Wilisch, Annette ^a   Vandekerckhove, Bart ^c   Hünig, Thomas ^a   Schalke, Berthold ^b   Schneider, Christiane ^a   Tzartos, Socrates ^d   Kalbacher, Hubert ^e   Müller Hermelink, Hans Konrad ^a   Marx, Alexander ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL MATURATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMOMA;

EID: 0031779306     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Aarli JA, Stefansson K, Marton LS, and Wollmann RL (1990). Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 82:284-288.
2. Brooks Worrell BM, Starkebaum GA, Greenbaum C, and Palmer JP (1996). Peripheral blood mononuclear cells of insulin-dependent diabetic patients respond to multiple islet cell proteins. J Immunol 157:5668-5674.
3. Carlow DA, Teh SJ, and Teh HS (1992a). Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium. J Immunol 148:2988-2995.
4. Carlow DA, van Oers NS, Teh SJ, and Teh HS (1992b). Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interactions. J Immunol 148:1595-1603.
5. Dardenne M, Savino W, and Bach JF (1987). Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody. Am J Pathol 126:194-198.
6. Fujii Y, Hayakawa M, Inada K, and Nakahara K (1990). Lymphocytes in thymoma: Association with myasthenia gravis is correlated with increased number of single-positive cells. Eur J Immunol 20:2355-2358.
7. Hohlfeld R (1990). Myasthenia gravis and thymoma: Paraneoplastic failure of neuromuscular transmission (editorial; comment). Lab Invest 62:241-243.
8. Hohlfeld R, Toyka KV, Heininger K, Grosse Wilde H, and Kalies I (1984). Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 310:244-246.
9. Hori T, Cupp J, Wrighton N, Lee F, and Spits H (1991). Identification of a novel human thymocyte subset with a phenotype of CD3- CD4+ CD8 alpha + beta-1: Possible progeny of the CD3- CD4- CD8- subset. J Immunol 146: 4078-4084.
10. Huesmann M, Scott B, Kisielow P, and von Boehmer H (1991). Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66:533-540.
11. Jenkinson EJ, Anderson G, and Owen JJ (1992). Studies on T cell maturation on defined thymic stromal cell populations in vitro. J Exp Med 176:845-853.
12. Kaab G, Brandi G, Marx A, Wekerle H, and Bradl M (1996). The myelin basic protein-specific T cell repertoire in (transgenic) Lewis rat/SCID mouse chimeras: Preferential V beta 8.2 T cell receptor usage depends on an intact Lewis thymic microenvironment. Eur J Immunol 26:981-988.
13. Kirchner T, Tzartos S, Hoppe F, Schalke B, Wekerle H, and Müller-Hermelink HK (1988). Pathogenesis of myasthenia gravis: Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol 130:268-280.
14. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, and Müller-Hermelink HK (1992). Well-differentiated thymic carcinoma: An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16:1153-1169.
15. Kraft DL, Weissman IL, and Waller EK (1993). Differentiation of CD3-4-8- human fetal thymocytes in vivo: Characterization of a CD3-4+8- intermediate. J Exp Med 178:265-277.
16. Lauriola L, Musiani P, Ranelletti FO, Maggiano N, and Piantelli M (1983). Human thymoma lymphocyte mitogenesis: Glucocorticoid inhibitory capacity as a function of the size of the more mature T cell subset. Clin Exp Immunol 52:477-484.
17. Lindstrom J, Shelton D, and Fujii Y (1988). Myasthenia gravis. Adv Immunol 42:233-284.
18. Marino M and Müller-Hermelink HK (1985). Thymoma and thymic carcinoma: Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407:119-149.
19. Marx A, Kirchner T, Hoppe F, O'Connor R, Schalke B, Tzartos S, and Müller-Hermelink HK (1989). Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol 134:865-877.
20. Marx A, O'Connor R, Geuder KI, Hoppe F, Schalke B, Tzartos S, Kalies I, Kirchner T, and Müller-Hermelink HK (1990). Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas (see comments). Lab Invest 62:279-286.
21. Marx A, Geuder KI, Schoepfer R, Tzartos S, Kristoffersson U, Schalke B, Kirchner T, and Müller-Hermelink HK (1991). Analysis of the acetylcholine receptor epitope-bearing protein p153 in thymomas favours "false-positive T-cell selection" as a mechanism of paraneoplastic myasthenia gravis. In: Imhof BA, editor: Lymphatic tissues and in vivo immune responses. New York: Marcel Decker, 577-583.
22. Marx A, Kirchner T, Greiner A, Müller-Hermelink HK, Schalke B, and Osborn M (1992). Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet 339:707-708.
23. Marx A, Kirchner T, Greiner A, Schalke B, and Müller-Hermelink HK (1993). Myasthenia gravis-associated thymic epithelial tumors express neurofilaments and are associated with antiaxonal autoimmunity. Ann NY Acad Sci 681:107-109.
24. Marx A, Wilisch A, Schultz A, Greiner A, Magi B, Pallini V, Schalke B, Toyka K, Nix W, Kirchner T, and Müller-Hermelink HK (1996). Expression of neurofilaments and of a titin epitope in thymic epithelial tumors: Implications for the pathogenesis of myasthenia gravis. Am J Pathol 148:1839-1850.
25. Marx A, Wilisch A, Schultz A, Gattenlohner S, Nenninger R, and Muller-Hermelink HK (1997). Pathogenesis of myasthenia gravis. Virchows Arch 430:355-364.
26. Masaoka A, Monden Y, Nakahara K, and Tanioka T (1981). Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485-2492.
27. Melms A, Malcherek G, Gern U, Wietholter H, Muller CA, Schoepfer R, and Lindstrom J (1992). T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: Heterogeneity of antigenic sites on the alpha-subunit. Ann Neurol 31:311-318.
28. Müller-Hermelink HK, Marx A, Geuder K, and Kirchner T (1993). The pathological basis of thymoma-associated myasthenia gravis. Ann NY Acad Sci 21:56-65.
29. Müller-Hermelink HK, Marx A, and Kirchner T (1994). Advances in the diagnosis and classification of thymic epithelial tumors. In: Anthony P, MacSween R, editors: Recent advances in histopathology. Edinburgh: Churchill Livingstone, 49-63.
30. Palestro G, Geuna M, Novero D, Godio L, Ciccone G, and Azzoni L (1990). Immunophenotype of thymoma-associated lymphoid cell component of T-cell type: A new analytic procedure in keeping with structural heterogeneities. Virchows Arch B Cell Pathol Incl Mol Pathol 59:297-304.
31. Penit C (1990). Positive selection is an early event in thymocyte differentiation: High TCR expression by cycling immature thymocytes precedes final maturation by several days. Int Immunol 2:629-638.
32. Petrie HT, Hugo P, Scollay R, and Shortman K (1990). Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro. J Exp Med 172:1583-1588.
33. Petrie HT, Strasser A, Harris AW, Hugo P, and Shortman K (1993). CD4+8- and CD4-8+ mature thymocytes require different post-selection processing for final development. J Immunol 151:1273-1279.
34. Pircher H, Ohashi PS, Boyd RL, Hengartner H, and Brduscha K (1994). Evidence for a selective and multi-step model of T cell differentiation: CD4+CD8 low thymocytes selected by a transgenic T cell receptor on major histocompatibility complex class I molecules. Eur J Immunol 24:1982-1987.
35. Rosai J and Levine GD (1976). Atlas of tumor pathology: Tumors of the thymus. Washington: Armed Forces Institute of Pathology.
36. Schoepfer R, Luther M, and Lindstrom J (1988). The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor: Cloning of the alpha-subunit cDNA. FEBS Lett 226:235-240.
37. Shortman K, Vremec D, and Egerton M (1991). The kinetics of T cell antigen receptor expression by subgroups of CD4+8+ thymocytes: Delineation of CD4+8+3(2+) thymocytes as post-selection intermediates leading to mature T cells. J Exp Med 173:323-332.
38. Sommer N, Willcox N, Harcourt GC, and Newsom Davis J (1990). Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol 28:312-319.
39. Sommer N, Harcourt GC, Willcox N, Beeson D, and Newsom Davis J (1991). Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 41:1270-1276.
40. Spits H, Lanier LL, and Phillips JH (1995). Development of human T and natural killer cells. Blood 85:2654-2670.
41. Swat W, Dessing M, von Boehmer H, and Kisielow P (1993). CD69 expression during selection and maturation of CD4+8+ thymocytes. Eur J Immunol 23:739-746.
42. Takahama Y, Letterio JJ, Suzuki H, Farr AG, and Singer A (1994). Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta. J Exp Med 179:1495-1506.
43. Takeuchi Y, Fujii Y, Okumura M, Inada K, Nakahara K, and Matsuda H (1993). Characterization of CD4+ single positive cells that lack CD3 in the human thymus. Cell Immunol 151:481-490.
44. Takeuchi Y, Fujii Y, Okumura M, Inada K, Nakahara K, and Matsuda H (1995). Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus. Cell Immunol 161:181-187.
45. Tzartos SJ and Remoundos MS (1992). Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit: Dissecting a potentially myasthenogenic epitope. Eur J Biochem 207:915-922.
46. van Ewijk W, Shores EW, and Singer A (1994). Crosstalk in the mouse thymus. Immunol Today 15:214-217.
47. Vanhecke D, Leclercq G, Plum J, and Vandekerckhove B (1995a). Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. J Immunol 155:1862-1872.
48. Vanhecke D, Verhasselt B, Debacker V, Leclercq G, Plum J, and Vandekerckhove B (1995b). Differentiation to T helper cells in the thymus: Gradual acquisition of T helper cell function by CD3+CD4+ cells. J Immunol 155:4711-4718.
49. Verbeek S, Izon D, Hofhuis F, Robanus Maandag E, te Riele H, van de Wetering M, Oosterwegel M, Wilson A, MacDonald HR, and Clevers H (1995). An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature 374:70-74.
50. Vincent A (1994). Aetiological factors in development of myasthenia gravis. Adv Neuroimmunol 4:355-371.
51. Willcox N (1993). Myasthenia gravis. Curr Opin Immunol 5:910-917.
52. Willcox N, Schluep M, Ritter MA, Schuurman HJ, Newsom Davis J, and Christensson B (1987). Myasthenic and nonmyasthenic thymoma: An expansion of a minor cortical epithelial cell subset? Am J Pathol 127:447-460.